Dmitriy V Ivashchenko

15PUBLICATIONS
53CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersChild and adolescent developmentAdolescent healthOptical technology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Sep 26, 2026
Genetic Polymorphisms CYP3A4*22, CYP3A5*3, and CYP2D6 Predicted Phenotypes Are Not Associated with Antipsychotic Treatment Outcomes in Neurotypical Prepubertal Boys with Conduct Disorders.

|May 13, 2026
Impact of Pharmacogenetic Markers on the Efficacy of Neoadjuvant FLOT Chemotherapy in Patients with Gastric and Gastroesophageal Junction Adenocarcinoma.

|Mar 28, 2026
Antidepressant-Induced Apathy in Adolescents with a Depressive Episode While Taking Sertraline: Results of 8-Week Observational Study with Pharmacogenetic Testing for CYP2C19.

Dmitriy V Ivashchenko, Sergey V Grass, Vitaliy V Sobur

|Nov 24, 2025
[Associations of polymorphic variants of CYP2C19*2, *17 with effectiveness and safety of sertraline in adolescents with a depressive episode and suicidal tendencies].

D V Ivashchenko, S V Grass, V V Sobur

|May 08, 2024
Exploring Risk Factors for Adverse Reactions in Children with an Acute Psychotic Episode Using the Global Trigger Tool: Does Age Matter?

Dmitriy V Ivashchenko, Nina I Buromskaya, Pavel V Shimanov

|Sep 14, 2023
Genetic markers associated with adverse reactions of radioiodine therapy in thyroid cancer patients.

Natalia P Denisenko, Anastasia A Kachanova, Ivan V Sychev

Pageof 3

Frequent Collaborators

9 joint publications

Dmitry Sychev

5 joint publications

Kristina A Akmalova

5 joint publications

Anastasia A Kachanova

4 joint publications

Elena A Grishina